Amos Stemmer

8PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)General practiceInnate immunityRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2026
Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

|Oct 27, 2022
Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study.

Eldad Elnekave, Eytan Ben Ami, Sivan Shamai

|Aug 02, 2022
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study.

Noa Eliakim-Raz, Amos Stemmer, Yaara Leibovici-Weisman

|May 14, 2022
Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.

Erez Bar-Haim, Noa Eliakim-Raz, Amos Stemmer

|Jul 02, 2021
Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer.

Amir Onn, Teodor Gottfried, Amos Stemmer

|Oct 21, 2020
Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis.

Amos Stemmer, Inbal Shafran, Salomon M Stemmer

Pageof 2

Frequent Collaborators

2 joint publications

Orna Bregman-Amitai

2 joint publications

Erez Bar-Haim

1 joint publications

Ran Shadmi

1 joint publications

Denitza Blagev